211 related articles for article (PubMed ID: 36780067)
21. Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism.
Cristina EV; Alberto F
Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):861-875. PubMed ID: 30665551
[TBL] [Abstract][Full Text] [Related]
22. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
[TBL] [Abstract][Full Text] [Related]
23. Familial isolated hyperparathyroidism caused by single adenoma: a distinct entity different from multiple endocrine neoplasia.
Watanabe T; Tsukamoto F; Shimizu T; Sugimoto T; Taguchi T; Nishisho I; Nakazawa H; Shiba E; Shishiba Y; Takai S
Endocr J; 1998 Oct; 45(5):637-46. PubMed ID: 10395244
[TBL] [Abstract][Full Text] [Related]
24. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
25. Molecular genetics of primary and secondary hyperparathyroidism.
Dotzenrath C; Goretzki PE; Farnebo F; Teh BT; Weber G; Röher HD; Larsson C
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():105-7. PubMed ID: 8981014
[TBL] [Abstract][Full Text] [Related]
26. Familial parathyroid tumors: diagnosis and management.
Stålberg P; Carling T
World J Surg; 2009 Nov; 33(11):2234-43. PubMed ID: 19184636
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of Parathyroid Carcinoma and Atypical Parathyroid Neoplasms in 153 Patients With Multiple Endocrine Neoplasia Type 1: Case Series and Literature Review.
Song A; Yang Y; Liu S; Nie M; Jiang Y; Li M; Xia W; Wang O; Xing X
Front Endocrinol (Lausanne); 2020; 11():557050. PubMed ID: 33101196
[No Abstract] [Full Text] [Related]
28. Genetic testing in multiple endocrine neoplasia and related syndromes.
Calender A
Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
[TBL] [Abstract][Full Text] [Related]
29. Parathyroid carcinoma occurred in two glands in multiple endocrine neoplasia 1: a report on a rare case.
Omi Y; Horiuchi K; Haniu K; Tokura M; Nagai E; Isozaki O; Nagashima Y; Okamoto T
Endocr J; 2018 Feb; 65(2):245-252. PubMed ID: 29225207
[TBL] [Abstract][Full Text] [Related]
30. Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.
Frank-Raue K; Rondot S; Hoeppner W; Goretzki P; Raue F; Meng W
J Clin Endocrinol Metab; 2005 Jul; 90(7):4063-7. PubMed ID: 15870131
[TBL] [Abstract][Full Text] [Related]
31. Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up.
Twigt BA; Scholten A; Valk GD; Rinkes IH; Vriens MR
Orphanet J Rare Dis; 2013 Apr; 8():50. PubMed ID: 23547958
[TBL] [Abstract][Full Text] [Related]
32. Familial and Hereditary Forms of Primary Hyperparathyroidism.
Cetani F; Saponaro F; Borsari S; Marcocci C
Front Horm Res; 2019; 51():40-51. PubMed ID: 30641519
[TBL] [Abstract][Full Text] [Related]
33. Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation.
Shibata Y; Yamazaki M; Takei M; Uchino S; Sakurai A; Komatsu M
Endocr J; 2015; 62(7):627-32. PubMed ID: 25959515
[TBL] [Abstract][Full Text] [Related]
34. Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.
Walls GV; Stevenson M; Lines KE; Newey PJ; Reed AAC; Bowl MR; Jeyabalan J; Harding B; Bradley KJ; Manek S; Chen J; Wang P; Williams BO; Teh BT; Thakker RV
Oncogene; 2017 Jul; 36(28):4025-4036. PubMed ID: 28288139
[TBL] [Abstract][Full Text] [Related]
35. Primary Hyperparathyroidism Focused on Molecular Pathogenesis.
Gómez Sáez JM
Eur Endocrinol; 2014 Aug; 10(2):153-156. PubMed ID: 29872481
[TBL] [Abstract][Full Text] [Related]
36. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
Parfitt J; Harris M; Wright JM; Kalamchi S
J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
[TBL] [Abstract][Full Text] [Related]
37. Genetics of Hyperparathyroidism, Including Parathyroid Cancer.
Simonds WF
Endocrinol Metab Clin North Am; 2017 Jun; 46(2):405-418. PubMed ID: 28476229
[TBL] [Abstract][Full Text] [Related]
38. Involvement of the MEN1 gene locus in familial isolated hyperparathyroidism.
Villablanca A; Wassif WS; Smith T; Höög A; Vierimaa O; Kassem M; Dwight T; Forsberg L; Du Q; Learoyd D; Jones K; Stranks S; Juhlin C; Teh BT; Carling T; Robinson B; Larsson C
Eur J Endocrinol; 2002 Sep; 147(3):313-22. PubMed ID: 12213668
[TBL] [Abstract][Full Text] [Related]
39. Somatic mutation of the MEN1 gene in parathyroid tumours.
Heppner C; Kester MB; Agarwal SK; Debelenko LV; Emmert-Buck MR; Guru SC; Manickam P; Olufemi SE; Skarulis MC; Doppman JL; Alexander RH; Kim YS; Saggar SK; Lubensky IA; Zhuang Z; Liotta LA; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
Nat Genet; 1997 Aug; 16(4):375-8. PubMed ID: 9241276
[TBL] [Abstract][Full Text] [Related]
40. A MEN1 Patient Presenting With Multiple Parathyroid Adenomas and Transient Hypercortisolism: A Case Report and Literature Review.
Chen F; Xu Q; Yue W; Yu X; Shao S
Front Endocrinol (Lausanne); 2022; 13():802453. PubMed ID: 35370956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]